Clinical Trials Browser

Interventional × Non-small Cell Lung Cancer Metastatic × Erlotinib Hydrochloride × Clear all

NCT01471964 2018-05-17

Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer

Phase 1/2 Terminated

Non-small Cell Lung Cancer Metastatic

NCT00701558 2016-06-24

A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Unresectable Advanced and/or Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

20 enrolled 8 charts

Non-small Cell Lung Cancer Metastatic